Media Kit

Press Releases

ScarX Therapeutics closes $2 million Series A financing

AccelRx/BDC make second portfolio investment in ScarX Therapeutics

Ontario advancing nine medical research projects in cancer, heart disease and sleep apnea to market

Zucara Therapeutics Inc. developing drug to prevent hypoglycemic episodes for people with diabetes

Corporate

About MaRS Innovation

MaRS Innovation Logo
Our Experts